https://thepharmacanada.ca/health-canada-approves-empaveli-pegcetacoplan-for-c3g-ic-mpgn/2026-06-16T09:58:52+00:00https://thepharmacanada.ca/health-canada-grants-noc-to-saphnelo-anifrolumab-sc-autoinjector-for-sle/2026-06-16T09:59:10+00:00https://thepharmacanada.ca/health-canada-approves-denoza-a-biosimilar-to-prolia-denosumab/2026-06-16T09:40:05+00:00https://thepharmacanada.ca/health-canada-clears-cta-for-aftx-201-in-bag3-dcm-to-be-evaluated-in-phase-1-2-upbeat-trial/2026-06-16T09:34:38+00:00https://thepharmacanada.ca/health-canada-approves-cysklar-cysteamine-ophthalmic-solution-for-cystinosis-related-corneal-crystals/2026-06-16T09:59:54+00:00https://thepharmacanada.ca/health-canada-grants-noc-to-semaglutide-injection-by-dr-reddys-laboratories-first-generic-approved-in-canada/2026-06-16T10:03:31+00:00https://thepharmacanada.ca/pharmascience-canada-launches-pms-dolutegravir-in-canada/2026-05-13T05:08:12+00:00https://thepharmacanada.ca/health-canada-licenses-new-software-for-minimed-780g-system-expanding-flexibility-and-type-2-diabetes-use/2026-06-16T10:03:16+00:00https://thepharmacanada.ca/health-canada-authorizes-prupgolyv-golimumab-by-jamp-pharma-expanding-immunology-biosimilars-portfolio/2026-06-16T10:01:20+00:00https://thepharmacanada.ca/abbvie-partners-with-biolabs-to-launch-biolabs-university-of-toronto-supporting-biotech-innovation/2026-06-16T10:02:46+00:00https://thepharmacanada.ca/health-canada-approves-bosaya-denosumab-and-vevzuo-denosumab-by-biocon/2026-06-16T10:03:02+00:00https://thepharmacanada.ca/well-health-technologies-partners-with-alivecor-to-offer-cardiologist-reviewed-ecg-insights-via-kardia-app-in-canada/2026-06-16T09:33:42+00:00https://thepharmacanada.ca/the-innovation-paradox-can-biopharma-afford-its-own-breakthroughs/2026-06-16T10:23:45+00:00https://thepharmacanada.ca/from-blockbusters-to-precision-therapies-is-the-pharma-model-being-rewritten/2026-06-16T10:24:14+00:00https://thepharmacanada.ca/ai-in-drug-development-competitive-advantage-or-industry-baseline/2026-06-16T10:29:48+00:00https://thepharmacanada.ca/clinical-trials-are-broken-can-decentralization-actually-fix-them/2026-06-16T10:30:13+00:00https://thepharmacanada.ca/pricing-access-and-the-global-pushback-against-pharma-margins/2026-06-16T10:30:52+00:00https://thepharmacanada.ca/the-rise-of-real-world-evidence-science-strategy-or-shortcut/2026-06-16T09:26:20+00:00https://thepharmacanada.ca/digital-health-fatigue-are-we-entering-the-consolidation-era/2026-06-16T10:31:30+00:00https://thepharmacanada.ca/biomanufacturing-2-0-the-race-for-resilient-localized-supply-chains/2026-06-16T10:32:33+00:00https://thepharmacanada.ca/patient-centricity-buzzword-or-business-model-transformation/2026-06-16T09:30:28+00:00https://thepharmacanada.ca/the-talent-crisis-in-healthcare-who-will-build-the-future-of-medicine/2026-06-16T09:32:02+00:00https://thepharmacanada.ca/the-patent-cliff-returns-can-pharma-outrun-billions-in-lost-exclusivity/2026-06-16T09:25:49+00:00https://thepharmacanada.ca/the-obesity-drug-gold-rush-healthcare-breakthrough-or-market-frenzy/2026-06-16T09:25:20+00:00https://thepharmacanada.ca/data-is-the-new-drug-who-will-control-the-future-of-healthcare-intelligence/2026-06-16T09:24:42+00:00https://thepharmacanada.ca/cell-and-gene-therapy-manufacturing-the-industrys-biggest-bottleneck/2026-06-16T09:23:34+00:00https://thepharmacanada.ca/beyond-esg-is-sustainability-becoming-a-core-pharma-strategy/2026-06-16T09:22:32+00:00https://thepharmacanada.ca/rare-diseases-big-business-why-pharma-is-betting-on-small-patient-populations/2026-06-16T09:21:38+00:00https://thepharmacanada.ca/the-future-of-vaccines-after-covid-19-momentum-or-market-slowdown/2026-06-16T09:21:09+00:00https://thepharmacanada.ca/pharmas-reputation-problem-can-trust-be-rebuilt/2026-06-16T09:20:25+00:00https://thepharmacanada.ca/companion-diagnostics-the-silent-engine-behind-precision-medicine/2026-06-16T09:19:31+00:00https://thepharmacanada.ca/the-next-frontier-in-oncology-moving-from-treatment-to-early-detection/2026-06-16T09:18:59+00:00https://thepharmacanada.ca/healthcare-cybersecurity-is-pharma-prepared-for-the-next-digital-threat/2026-06-16T07:20:07+00:00https://thepharmacanada.ca/the-reinvention-of-the-cdmo-industry-strategic-partner-or-competitive-threat/2026-06-16T07:19:42+00:00https://thepharmacanada.ca/womens-health-is-finally-getting-attention-but-is-investment-keeping-pace/2026-06-16T07:18:51+00:00https://thepharmacanada.ca/the-future-of-biosimilars-cost-saver-or-innovation-disruptor/2026-06-16T07:18:23+00:00https://thepharmacanada.ca/quantum-computing-in-pharma-hype-cycle-or-scientific-revolution/2026-06-16T07:17:57+00:00https://thepharmacanada.ca/healthcare-consumerism-are-patients-becoming-pharmas-new-customers/2026-06-16T07:17:31+00:00https://thepharmacanada.ca/the-geopolitics-of-medicine-how-global-tensions-are-reshaping-pharma-strategy/2026-06-16T07:17:02+00:00https://thepharmacanada.ca/the-longevity-economy-is-pharma-ready-for-the-ageing-population-boom/2026-06-16T07:03:55+00:00https://thepharmacanada.ca/the-rise-of-preventive-healthcare-can-pharma-shift-from-treating-disease-to-preventing-it/2026-06-16T07:03:31+00:00https://thepharmacanada.ca/pharma-and-ai-partnerships-collaboration-boom-or-dependency-risk/2026-06-16T09:23:02+00:00https://thepharmacanada.ca/ai-in-drug-development-competitive-advantage-or-industry-baseline-in-canadian-health/2026-06-16T07:03:08+00:00https://thepharmacanada.ca/felix-health-to-lower-semaglutide-prices-in-canada-as-treatment-cost-remains-a-major-barrier-for-glp-1-patients/2026-06-16T07:19:15+00:00https://thepharmacanada.ca/celystra-pharma-launches-in-quebec-with-20m-backing-and-first-rare-disease-therapy-approved-by-health-canada/2026-06-16T09:29:11+00:00https://thepharmacanada.ca/bc-pharmacare-adds-coverage-for-revestive-teduglutide-by-takeda-canada-inc-for-sbs-patients-in-british-columbia/2026-06-16T09:28:09+00:00https://thepharmacanada.ca/health-canada-authorizes-istatis-hepatitis-b-surface-antigen-test-by-biolytical-laboratories-marking-a-north-american-first/2026-06-16T09:27:20+00:00https://thepharmacanada.ca/health-canada-approves-kisunla-donanemab-by-lilly-canada-for-early-alzheimers-disease/2026-06-16T09:29:50+00:00https://thepharmacanada.ca/health-canada-grants-noc-to-fabhalta-iptacopan-by-novartis-pharmaceuticals-canada-inc-for-c3-glomerulopathy/2026-06-16T09:31:04+00:00https://thepharmacanada.ca/health-canada-approves-apo-semaglutide-injection-by-apotex-as-a-generic-equivalent-to-ozempic-semaglutide/2026-06-16T09:31:33+00:00https://thepharmacanada.ca/gsk-files-bepirovirsen-for-priority-review-in-canada-backed-by-phase-3-b-well-trials/2026-06-16T10:03:44+00:00https://thepharmacanada.ca/health-canada-approves-vueway-gadopiclenol-by-bracco-imaging-for-ce-mri/2026-06-16T10:00:09+00:00https://thepharmacanada.ca/alk-reports-health-canada-approval-for-needle-free-anaphylaxis-spray/2026-06-16T09:59:40+00:00https://thepharmacanada.ca/apotex-expands-ophthalmology-portfolio-with-health-canada-approval-of-clobivis/2026-06-16T09:32:50+00:00https://thepharmacanada.ca/apotex-launches-generic-apo-semaglutide-injection-across-canada/2026-06-16T07:02:36+00:00https://thepharmacanada.ca/dr-reddys-laboratories-launches-generic-semaglutide-injection-in-canada/2026-06-16T07:02:03+00:00https://thepharmacanada.ca/novartis-expands-health-equity-initiative-in-canada-with-focus-on-womens-health/2026-06-16T07:01:46+00:00https://thepharmacanada.ca/biosyent-secures-health-canada-approval-for-first-liquid-levothyroxine-option-in-canada/2026-06-16T07:01:04+00:00https://thepharmacanada.ca/orimed-pharma-expands-prluxa-d-vitamin-d-portfolio-in-canada/2026-06-16T07:00:34+00:00https://thepharmacanada.ca/pshsa-launches-intelligent-safety-to-bring-ai-driven-workplace-safety-tools-to-ontarios-public-sector/2026-06-16T07:00:12+00:00https://thepharmacanada.ca/gsk-advances-access-discussions-for-blenrep-in-relapsed-or-refractory-multiple-myeloma/2026-06-16T06:59:51+00:00https://thepharmacanada.ca/phoenix-and-raven-launch-generic-semaglutide-for-canadians-through-telehealth/2026-06-16T06:59:31+00:00https://thepharmacanada.ca/optimi-health-prices-us15m-public-offering-ahead-of-nasdaq-debut/2026-06-16T06:34:52+00:00https://thepharmacanada.ca/csl-canada-marks-first-real-world-hemgenix-gene-therapy-treatment-for-hemophilia-b-in-canada/2026-06-16T06:33:38+00:00https://thepharmacanada.ca/hims-hers-launches-generic-semaglutide-access-platform-across-canada/2026-06-16T06:33:17+00:00https://thepharmacanada.ca/vertexs-suzetrigine-accepted-for-health-canada-review-in-acute-pain/2026-06-16T06:32:55+00:00https://thepharmacanada.ca/medexpress-canada-launches-generic-semaglutide-starting-at-cad-124-99/2026-06-16T06:32:58+00:00https://thepharmacanada.ca/roche-canadas-gazyva-receives-positive-reimbursement-recommendation-for-lupus-nephritis/2026-06-16T06:32:07+00:00https://thepharmacanada.ca/allergan-aesthetics-secures-health-canada-authorization-for-harmonyca-with-lidocaine/2026-06-16T06:31:37+00:00https://thepharmacanada.ca/brain-canada-backs-new-research-platforms-in-british-columbia-and-alberta/2026-06-16T06:31:08+00:00https://thepharmacanada.ca/apotex-secures-health-canada-approval-for-iheezo/2026-06-16T06:30:41+00:00https://thepharmacanada.ca/ontario-funds-braftovi-for-braf-mutant-mcrc-under-fast-program/2026-06-16T06:30:12+00:00https://thepharmacanada.ca/novo-nordisk-canada-expands-ozempic-savings-program/2026-06-16T06:29:43+00:00https://thepharmacanada.ca/vimy-pharma-files-ands-for-generic-semaglutide-in-canada/2026-06-16T06:29:13+00:00https://thepharmacanada.ca/vanflyta-gains-public-reimbursement-in-canada-for-flt3-itd-positive-aml/2026-06-16T06:28:52+00:00https://thepharmacanada.ca/tevimbra-receives-positive-canadian-reimbursement-recommendations-for-npc/2026-06-16T06:28:18+00:00https://thepharmacanada.ca/hims-hers-completes-eucalyptus-acquisition-to-expand-canadian-digital-health-platform/2026-06-16T06:27:44+00:00https://thepharmacanada.ca/sunshine-biopharma-secures-health-canada-approval-for-generic-rivaroxaban/2026-06-16T06:27:14+00:00https://thepharmacanada.ca/anixa-expands-ovarian-cancer-vaccine-ip-portfolio-in-canada/2026-06-16T06:14:16+00:00https://thepharmacanada.ca/kashiv-biosciences-advances-omalizumab-biosimilar-in-canada/2026-06-16T06:11:58+00:00https://thepharmacanada.ca/medexus-secures-canadian-rights-to-um171-cell-therapy-for-blood-cancers/2026-06-10T10:03:33+00:00https://thepharmacanada.ca/italfarmacos-duvyzat-receives-health-canada-priority-review-for-dmd/2026-06-10T10:23:21+00:00https://thepharmacanada.ca/chiesis-filsuvez-gets-health-canada-priority-review-for-epidermolysis-bullosa/2026-06-10T10:30:10+00:00https://thepharmacanada.ca/gsks-nucala-approved-in-canada-for-copd-patients-with-elevated-eosinophils/2026-06-11T07:24:49+00:00https://thepharmacanada.ca/ucbs-bimzelx-wins-cda-amc-reimbursement-support-for-hidradenitis-suppurativa/2026-06-11T07:32:48+00:00https://thepharmacanada.ca/bausch-healths-prokedi-secures-pcpa-deal-for-schizophrenia-access/2026-06-11T07:53:40+00:00https://thepharmacanada.ca/novo-nordisk-launches-updated-rybelsus-formulation-in-canada/2026-06-11T07:56:52+00:00https://thepharmacanada.ca/roches-lunsumio-gains-health-canada-approval-in-iv-and-sc-forms-for-follicular-lymphoma/2026-06-11T07:59:56+00:00https://thepharmacanada.ca/kye-launches-dyanavel-xr-for-adhd-in-canada/2026-06-11T08:05:47+00:00https://thepharmacanada.ca/bms-updates-breyanzi-monitoring-guidelines-in-canada/2026-06-18T07:11:18+00:00https://thepharmacanada.ca/heidi-ai-scribe-integrates-with-accuro-emr/2026-06-18T07:22:38+00:00https://thepharmacanada.ca/gsks-exdensur-approved-in-canada-for-severe-eosinophilic-asthma-and-crswnp/2026-06-18T07:51:00+00:00https://thepharmacanada.ca/lillys-zepbound-approved-for-sleep-apnea-in-canada/2026-06-18T09:16:11+00:00https://thepharmacanada.ca/samsung-bioepis-organon-expand-pyzchiva-deal-in-canada/2026-06-18T10:42:41+00:00https://thepharmacanada.ca/organon-henlius-launch-bildyos-and-tuzemty-in-canada/2026-06-24T06:23:14+00:00https://thepharmacanada.ca/takedas-zasocitinib-beats-deucravacitinib-in-psoriasis-phase-3-trial/2026-06-24T05:44:00+00:00https://thepharmacanada.ca/roches-itovebi-moves-closer-to-public-access-in-canada/2026-06-24T07:18:19+00:00